Navigation Links
Seambiotic USA and NASA Glenn Research Center Signed Agreement for Large Scale Microalgae Process Optimization
Date:7/6/2009

ASHKELON, Israel, July 6 /PRNewswire/ -- Seambiotic, a global leader in the development and production of marine microalgae for the nutraceutical and biofuel industries, has announced that its US subsidiary, Seambiotic USA, has entered into an agreement with NASA Glenn Research Center to develop an on-going collaborative R&D program for optimization of open-pond microalgae growth processes.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090706/352488 )

"Under a Space Act Agreement, NASA is partnering with Seambiotic USA to model growth processes for microalgae for use as aviation biofuel feedstock," said Prof. Ami Ben-Amotz, Chief Scientific Adviser to Seambiotic. "The goal of the Agreement is to make use of NASA's expertise in large scale computational modeling and combine it with Seambiotic's biological process modeling to make advances in biomass process cost reduction."

Under the Agreement, NASA Glenn and Seambiotic USA will work together to improve production processes and to study and qualify algae oil from alternative species and production processes as candidate aviation fuel at NASA's test facilities.

About NASA Glenn Research Center

The NASA John H. Glenn Research Center NASA Glenn Research Center (http://www.nasa.gov/glenn) is one of NASA's 10 field centers, empowered with the resources for developing cutting-edge technologies and advancing scientific research that address NASA's mission to pioneer the future in space exploration, scientific discovery and aeronautics research. Working in partnership with government, industry and academia, the center serves to maintain the US economy's global leadership while benefiting the lives of people around the world.

About Seambiotic USA

Seambiotic USA is a fully owned subsidiary of Seambiotic Ltd., located in Ashkelon, Israel. Seambiotic (http://www.seambiotic.com) was founded in 2003 to grow and process marine microalgae for the nutraceutical and biofuel industries. Seambiotic's research efforts include a pilot study at an Israeli Electric Corporation power station near the city Ashkelon, Israel, where various species of marine microalgae have been successfully cultivated using the power station's CO2 emissions released directly from their smokestacks; the microalgae are in turn used as feedstock for biofuel. Seambiotic technology reduces the cost of microalgae production significantly while lowering global warming by reducing industrial CO2 emissions. The company is currently in transition from the pilot plant stage to large scale industrial algae cultivation and production.

Contact: info@seambiotic.com


'/>"/>
SOURCE Seambiotic Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Iomai Chief Scientific Officer Dr. Gregory Glenn Details Development of Travelers Diarrhea Patch at Keystone Conference
2. Researchers unite to distribute quantum keys
3. Video: Axel Ullrich Named Winner of 2009 Dr. Paul Janssen Award for Biomedical Research
4. Morphotek(R), Inc. Announces a Research Collaboration Agreement with Synageva BioPharma Corporation to Develop Potential Treatments for Cancer and Infectious Disease
5. Stanford researchers find a quicker, cheaper way to sort isotopes
6. Nobel Laureate Lee Hartwell to Retire as President and Director of Fred Hutchinson Cancer Research Center in 2010
7. Elsevier Releases Results of Alternative Energy Research Leadership Study Identifying Top 25 Institutions Worldwide
8. OmniComm Systems Announces Acquisition of EDC Business of eResearchTechnology
9. The Lustgarten Foundation Awards Six Research Centers With Pancreatic Cancer Research Funding
10. Trubion Pharmaceuticals Announces Extension of Research Period Under Its Wyeth Collaboration
11. Researchers putting a freeze on oscillator vibrations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2017)... Village, CA (PRWEB) , ... August 17, 2017 ... ... technology for cancer research and personalized medicine, today announced the launch of a ... Kansas City, Missouri. The study’s goal is to evaluate the potential for early ...
(Date:8/16/2017)... ... August 16, 2017 , ... Today, 3Bar Biologics Inc ... $2M in funding from an impressive group of investors, including Rev1 Ventures, Maumee ... With this investment, 3Bar is broadening availability of its groundbreaking offering that uses ...
(Date:8/15/2017)... Charlotte, NC (PRWEB) , ... August 15, 2017 , ... ... in 2017, celebrating 10 years of successes helping medical technology companies and inventors develop ... company to a renowned full-service national engineering firm with a portfolio of clients in ...
(Date:8/15/2017)... , ... August 15, 2017 , ... The Conference ... on Immuno-Oncology 360° (IO360°) programming through a series of upcoming panels and events. The ... 7-9, 2018, at The Roosevelt Hotel in New York City. , “With our experience ...
Breaking Biology Technology:
(Date:3/30/2017)... The research team of The Hong Kong Polytechnic University (PolyU) ... ground breaking 3D fingerprint minutiae recovery and matching technology, pushing contactless ... use in identification, crime investigation, immigration control, security of access and ... ... A research team led by Dr Ajay Kumar ...
(Date:3/28/2017)... 2017 The report "Video Surveillance ... Servers, Storage Devices), Software (Video Analytics, VMS), and Service ... Forecast to 2022", published by MarketsandMarkets, the market was ... projected to reach USD 75.64 Billion by 2022, at ... base year considered for the study is 2016 and ...
(Date:3/24/2017)... Research and Markets has announced the addition of the ... Industry Forecast to 2025" report to their offering. ... The Global Biometric Vehicle Access ... 15.1% over the next decade to reach approximately $1,580 million by ... and forecasts for all the given segments on global as well ...
Breaking Biology News(10 mins):